NIH, Gates Foundation invest $200M to develop gene therapies for developing countries
The partnership will have a particular focus on therapies to treat sickle cell disease and HIV, with each party committing $100 million to the effort.
The partnership will have a particular focus on therapies to treat sickle cell disease and HIV, with each party committing $100 million to the effort.
The company plans to use the funding to support its various microbiome-based drug development programs in oncology, food allergy and bacterial infection.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
The Institute for Healthcare Improvement announced that it received a $9.6M grant from the Bill & Melinda Gates Foundation to reduce newborn mortality in Ethiopia.
While healthcare providers in the U.S. struggle with design challenges of electronic medical record systems, some other countries are still struggling to get basic paper records systems in place. A global healthcare design challenge funded by the Bill and Melinda Gates Foundation tasked designers with giving the children’s immunization record a makeover. Immunization programs are […]
The tropical disease dengue fever isn’t something we hear or worry about much in the U.S. So when virologists at the Centers for Disease Control and Prevention recently published study findings that a rare 2010 dengue outbreak in Florida came not from abroad but from a unique, local strain of the virus that’s evolved its […]
A vaccine developer focused on fighting infectious diseases like HSV-2, Pneumococcus and malaria has just gotten a $30 million vote of confidence from investors. Genocea Biosciences says its ATLAS platform mimics the human T cell immune response in the laboratory, allowing it to identify and test T cell antigens in less time and with more […]
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
iBio (NYSE:IBIO) is seeking to raise $10 million for its plant-based vaccine production in a public offering. The Newark, Delaware-based pharmaceutical company has priced 15,385,000 units at 65 cents per unit. Each unit includes one share of common stock and 0.75 of a warrant to purchase one share of common stock. The warrants will have an […]